Annual Total Liabilities
$745.23 M
+$673.18 M+934.21%
December 31, 2023
Summary
- As of February 8, 2025, RNAC annual total liabilities is $745.23 million, with the most recent change of +$673.18 million (+934.21%) on December 31, 2023.
- During the last 3 years, RNAC annual total liabilities has risen by +$561.79 million (+306.25%).
- RNAC annual total liabilities is now at all-time high.
Performance
RNAC Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$454.56 M
+$5.37 M+1.20%
September 1, 2024
Summary
- As of February 8, 2025, RNAC quarterly total liabilities is $454.56 million, with the most recent change of +$5.37 million (+1.20%) on September 1, 2024.
- Over the past year, RNAC quarterly total liabilities has increased by +$12.56 million (+2.84%).
- RNAC quarterly total liabilities is now -39.00% below its all-time high of $745.23 million, reached on December 31, 2023.
Performance
RNAC Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
RNAC Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +934.2% | +2.8% |
| 3 y3 years | +306.3% | +530.8% |
| 5 y5 years | +1393.5% | +530.8% |
RNAC Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +934.2% | -39.0% | +894.6% |
| 5 y | 5-year | at high | +934.2% | -39.0% | +894.6% |
| alltime | all time | at high | +2069.9% | -39.0% | +2135.3% |
Cartesian Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $454.56 M(+1.2%) |
| Jun 2024 | - | $449.20 M(+1.6%) |
| Mar 2024 | - | $442.01 M(-40.7%) |
| Dec 2023 | $745.23 M(+934.2%) | $745.23 M(+1530.5%) |
| Sep 2023 | - | $45.70 M(-38.3%) |
| Jun 2023 | - | $74.06 M(-8.7%) |
| Mar 2023 | - | $81.11 M(+12.6%) |
| Dec 2022 | $72.06 M(-47.5%) | - |
| Dec 2022 | - | $72.06 M(-22.8%) |
| Sep 2022 | - | $93.36 M(-5.2%) |
| Jun 2022 | - | $98.46 M(+9.5%) |
| Mar 2022 | - | $89.93 M(-34.5%) |
| Dec 2021 | $137.36 M(-25.1%) | $137.36 M(-26.1%) |
| Sep 2021 | - | $185.89 M(+0.6%) |
| Jun 2021 | - | $184.74 M(-5.9%) |
| Mar 2021 | - | $196.32 M(+7.0%) |
| Dec 2020 | $183.44 M | $183.44 M(-2.6%) |
| Sep 2020 | - | $188.38 M(+113.4%) |
| Jun 2020 | - | $88.26 M(-9.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $97.56 M(+7.0%) |
| Dec 2019 | $91.17 M(+82.7%) | $91.17 M(+105.1%) |
| Sep 2019 | - | $44.46 M(-5.2%) |
| Jun 2019 | - | $46.89 M(-1.6%) |
| Mar 2019 | - | $47.66 M(-4.5%) |
| Dec 2018 | $49.90 M(+1.2%) | $49.90 M(-0.8%) |
| Sep 2018 | - | $50.32 M(+2.3%) |
| Jun 2018 | - | $49.17 M(+1.7%) |
| Mar 2018 | - | $48.35 M(-1.9%) |
| Dec 2017 | $49.29 M(+43.5%) | $49.29 M(+10.4%) |
| Sep 2017 | - | $44.65 M(+14.9%) |
| Jun 2017 | - | $38.84 M(+18.5%) |
| Mar 2017 | - | $32.77 M(-4.6%) |
| Dec 2016 | $34.34 M(-78.4%) | $34.34 M(+68.9%) |
| Sep 2016 | - | $20.34 M(-9.8%) |
| Jun 2016 | - | $22.54 M(+10.6%) |
| Mar 2016 | - | $20.38 M(-87.2%) |
| Dec 2015 | $159.32 M(+44.9%) | $159.32 M |
| Dec 2014 | $109.98 M | - |
FAQ
- What is Cartesian Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Cartesian Therapeutics?
- What is Cartesian Therapeutics annual total liabilities year-on-year change?
- What is Cartesian Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Cartesian Therapeutics?
- What is Cartesian Therapeutics quarterly total liabilities year-on-year change?
What is Cartesian Therapeutics annual total liabilities?
The current annual total liabilities of RNAC is $745.23 M
What is the all time high annual total liabilities for Cartesian Therapeutics?
Cartesian Therapeutics all-time high annual total liabilities is $745.23 M
What is Cartesian Therapeutics annual total liabilities year-on-year change?
Over the past year, RNAC annual total liabilities has changed by +$673.18 M (+934.21%)
What is Cartesian Therapeutics quarterly total liabilities?
The current quarterly total liabilities of RNAC is $454.56 M
What is the all time high quarterly total liabilities for Cartesian Therapeutics?
Cartesian Therapeutics all-time high quarterly total liabilities is $745.23 M
What is Cartesian Therapeutics quarterly total liabilities year-on-year change?
Over the past year, RNAC quarterly total liabilities has changed by +$12.56 M (+2.84%)